Yvette Anderson MPS[/caption]
Systemic corticosteroids for dyspnoea
The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer.
Dyspnoea affects almost 70% of advanced cancer patients at the...
New alliance between PSA and SHPA announced
At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...
Care without caps
Rural Victorian pharmacist Kelly Abbott MPS reaches her 30 HMR cap every month, continuing to advocate for person-centred care.
The pain of uncertainty: Managing pain without codeine
With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...
Pharmacists in 2023 – unlocking the future of pharmacy
A major new PSA report, Pharmacists in 2023, reveals a roadmap for the changes needed to ensure the profession’s potential is realised – and...
Complementary medicines: Rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by joint inflammation. The immune system attacks the tissue lining the joints (synovial membrane), causing...
